Status:
COMPLETED
Switch Timely to Oral Medication
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
KU Leuven
Conditions:
IV Oral Switch
Appropriateness Review
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this study compare the effectiveness of an electronic note versus a telephone call to alert the prescriber of a possible IV to oral switch. Secondary endpoints are the time-to-switch and t...
Detailed Description
Methods o Study design A prospective, mono-centric, interrupted time series interventional study will be carried out starting in August 2015. Patients will be recruited hospital wide, except for pat...
Eligibility Criteria
Inclusion
- Therapy with prescriptions for levofloxacin (J01MA12), moxifloxacin (J01MA14), clarithromycin (J01FA09), fluconazole (J02AC01), clindamycin (J01FF01), acetaminophen (N02BE01), rifampicin (J04AB02), ornidazole (J01XD03) and metronidazole (J01XD01) in the hospitals CPOE from 01-08-2015 until 30-11-2015 for hospitalized patients.
Exclusion
- Therapy prescribed in PDMS (in casu: ICU)
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT03254407
Start Date
August 1 2015
End Date
August 1 2016
Last Update
August 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams Brabant, Belgium, 3000